Katsuhito Ihara

8PUBLICATIONS
53CO-AUTHORS
Nutrigenomics and personalised nutritionMajor global burdens of diseaseMedical biochemistry - proteins and peptides (incl. medical proteomics)PharmacogenomicsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Oct 10, 2025
Joslin Kidney Panel of Circulating Proteins: A Tool for ESKD Risk Discrimination and Individualized Diabetic Kidney Disease Treatment.

Andrzej S Krolewski, Jani K Haukka, Zaipul I Md Dom

|Apr 03, 2025
Frailty, Multimorbidity, and Polypharmacy: Exploratory Analyses of the Effects of Empagliflozin from the EMPA-KIDNEY Trial.

Kaitlin J Mayne, Rebecca J Sardell, Natalie Staplin

|Oct 31, 2024
Classification of Predictors of Rapid Development of Kidney Failure and Short-Term Changes in Concentration of Circulating Proteins.

Hiroki Kobayashi, Helen C Looker, Katsuhito Ihara

|Jul 01, 2024
Frailty, multimorbidity and polypharmacy: exploratory analyses of the effects of empagliflozin from the EMPA-KIDNEY trial.

Kaitlin J Mayne, Rebecca J Sardell, Natalie Staplin

|Aug 10, 2022
Neuroblastoma suppressor of tumorigenicity 1 is a circulating protein associated with progression to end-stage kidney disease in diabetes.

Hiroki Kobayashi, Helen C Looker, Eiichiro Satake

Pageof 2